Three FDA-approved GLP-1 medications are eligible under the bridge program when used to reduce excess body weight and maintain weight reduction: Wegovy (semaglutide), available as a weekly injection or daily oral tablet, manufactured by Novo Nordisk Zepbound (tirzepatide), available in the KwikPen autoinjector format, manufactured by Eli Lilly Foundayo (orforglipron), the first non-peptide, small-molecule oral GLP-1 for weight loss, recently FDA-approved and manufactured by Eli Lilly Each of these medications works by mimicking the activity of glucagon-like peptide-1, a hormone that regulates appetite, fullness, and blood sugar
Step 1: Medical Consultation & Evaluation Your journey begins with a private consultation with our wellness specialist
Im a sportsperson and have always struggled with intense acne due to sweat and tanning from the sun
10.1016/j.euroneuro.2015.04.016 47
Key Takeaways Nitric oxide helps blood and oxygen flow through your body
Recent bloodwork is required to help determine eligibility and support your safety before treatment